ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

A Study to Assess Menstrual Cramp Pain Associated With Primary Dysmenorrhea

ClinicalTrials.gov ID: NCT03448536

Public ClinicalTrials.gov record NCT03448536. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 5, 2026, 2:35 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-Blind, Randomized, Crossover Study to Assess Menstrual Cramp Pain Associated With Primary Dysmenorrhea

Study identification

NCT ID
NCT03448536
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Bayer
Industry
Enrollment
201 participants

Conditions and interventions

Conditions

Interventions

  • Acetaminophen (Tylenol Extra Strength) Drug
  • Naproxen Sodium, (Aleve, BAY117031) Drug

Drug

Eligibility (public fields only)

Age range
15 Years to 35 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 4, 2018
Primary completion
Sep 4, 2018
Completion
Sep 4, 2018
Last update posted
Oct 27, 2019

2018

United States locations

U.S. sites
8
U.S. states
5
U.S. cities
8
Facility City State ZIP Site status
Radiant Research, Inc. Chandler Arizona 85224
Radiant Research, Inc. Scottsdale Arizona 85251
Radiant Research, Inc. Pinellas Park Florida 33781
Radiant Research, Inc. Chicago Illinois 60602
Radiant Research, Inc. Akron Ohio 44311
Radiant Research, Inc. Cincinnati Ohio 45236
Radiant Research, Inc. Dallas Texas 75234
Synexus US, LP- Plano Plano Texas 75234

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03448536, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 27, 2019 · Synced May 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03448536 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →